About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Friday, September 12th, 2014

The QualityStocks
Daily Stock List


Telkonet, Inc. (TKOI)

RedChip, FeedBlitz, SmallCapVoice, Alternative Energy, CoolPennyStocks, BullRally, Stock Rich, and HotOTC reported previously on Telkonet, Inc. (TKOI), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Telkonet, Inc. is a foremost energy management technology provider. The Company offers hardware, software and services to commercial customers globally. Its complementary business divisions include EcoSmart™, an energy management technology platform featuring Recovery Time™ technology, and EthoStream®, one of the largest hospitality High-Speed Internet Access providers in the world. Telkonet’s shares trade on the OTC Markets’ OTCQB. The Company is based in Waukesha, Wisconsin.

Its EcoSmart™ family of products includes EcoInsight and EcoWave intelligent thermostats, the EcoView occupancy sensor, and the EcoGuard energy management outlet and EcoSwitch light switch. EcoSmart™ products can be employed in most building environments to decrease utility costs and enable remote monitoring and control using the EcoCentral Virtual Engineer management platform.

The Company’s energy management products have the power to reduce energy consumption, minimize carbon footprints and reduce the need for new power plants.  With EcoSmart™, Telkonet can provide and install any combination of intelligent thermostats, occupancy sensors, door contacts, and plug load control devices. All products can be networked to enhance energy efficiency and provide the above-mentioned remote monitoring capability. 

Telkonet’s EthoStream, the high-speed Internet access division of the Company, operates the largest hospitality HSIA network in the U.S. It supports more than 5 million users monthly. EthoStream offers solutions for any public access location, with a broad assortment of product and service offerings and one of the most complete management platforms available for HSIA networks.

Recently, Telkonet announced financial results for the second quarter ended June 30, 2014. Selected highlights include revenue of $4.4 million, an increase of 21 percent from $3.6 million in Q2 2013. Gross profit was $2.1 million, an increase of 43 percent from $1.5 million in Q2 2013. The Company’s net income was $219,085 versus a net loss of $(621,510) in Q2 2013.

This week, Telkonet announced the launch of its EcoCentral Virtual Engineer mobile applications for iOS and Android phones.  The native apps were internally created by the Company’s software engineers. The apps are the first applications developed within the energy management and efficiency market for commercial properties.

The mobile apps enable complete connectivity and control for Telkonet's EcoSmart solution. EcoSmart is the industry's only complete platform for energy and operational management and efficiency monitoring and controlling HVAC, plug load and lighting over any digital platform.

Telkonet, Inc. (TKOI), closed Friday's trading session at $0.171, down 4.47%, on 7,015 volume with 5 trades. The average volume for the last 60 days is 114,970 and the stock's 52-week low/high is $0.13/$0.30.

Titan Pharmaceuticals, Inc. (TTNP)

PennyStocks24, Penny Pick Finders, PennyStockProphet, SecretStockPromo, StockOnion, Planet Penny Stocks, Buzz Stocks, and SmarTrend Newsletters reported earlier on Titan Pharmaceuticals, Inc. (TTNP), and we are reporting on the Company today, here at the QualityStocks Daily Newsletter.

Titan Pharmaceuticals, Inc. is a biopharmaceutical company developing proprietary therapeutics chiefly for the treatment of central nervous system (CNS) disorders. Its main asset is Probuphine®. This product is the first slow-release implant formulation of buprenorphine hydrochloride (buprenorphine). Probuphine® is the first product to utilize ProNeura™ - a novel, proprietary, long-term drug delivery technology. Titan Pharmaceuticals has its corporate office in South San Francisco, California. The Company’s shares trade on the OTC Bulletin Board.

The Probuphine New Drug Application (NDA) was submitted to the U.S. Food and Drug Administration (FDA) in October of 2012 - seeking approval for the treatment of opioid dependence. The Company’s objective is to enter into one or more collaborations with capable pharmaceutical companies to commercialize Probuphine® in the U.S. and international markets, and to develop, potentially, the product for the treatment of chronic pain.

The ProNeura™ technology has the potential to be used in developing products for the treatment of other chronic conditions, such as Parkinson's disease. The design of Probuphine® is to maintain a stable, round-the-clock blood level of the medicine in patients for up to six months following a single treatment. A seven-day transdermal patch formulation of buprenorphine for the treatment of chronic pain was launched in the U.S. in 2011. Probuphine® is an investigational subdermal implant for the maintenance treatment of opioid dependence in adult patients. 

Additionally, Titan is entitled to royalty revenue of 8-10 percent of net sales of Fanapt® (iloperidone). This is an atypical antipsychotic compound being marketed in the U.S. for the treatment of schizophrenia by Novartis Pharma AG under a sub-license agreement based on a licensed U.S. patent that expires in October 2016 (does not include a possible six month pediatric extension).

Titan Pharmaceuticals announced this past April that the FDA provided clear guidance on the full clinical study protocol of Probuphine®. The study was submitted for FDA review in mid-March by Titan's partner, Braeburn Pharmaceuticals. Study completion is expected by the middle of next year. In July, Titan announced enrollment of the first patients in the Phase 3 clinical study to support resubmission of the New Drug Application (NDA) for Probuphine®.

In June, the Company announced that it received a Notice of Allowance from the U.S. Patent and Trademark Office (USPTO) for a patent application covering the sustained release of dopamine agonists utilizing ProNeura™. The patent, titled "Implantable Polymeric Device for Sustained Release of a Dopamine Agonist," provides intellectual property (IP) protection for Titan’s development program of ProNeura for Parkinson's disease. It carries a patent term to at least 2024. Like patents have been issued in Europe, Australia, Canada, Japan, Korea, Mexico, New Zealand, South Africa and Hong Kong. Patent applications are pending in Israel, India and China.

Titan Pharmaceuticals, Inc. (TTNP), closed Friday's trading session at $0.6316, down 2.08%, on 92,603 volume with 36 trades. The average volume for the last 60 days is 127,149 and the stock's 52-week low/high is $0.53/$1.27.

Triton Emission Solutions, Inc. (DSOX)

Gold Investment Letter reported this week on Triton Emission Solutions, Inc. (DSOX), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Triton Emission Solutions, Inc. develops and markets environmental and pollution emission control solutions to a global market. Its engineers work to build proprietary products that reduce harmful chemical emissions into the ocean and atmosphere. The Company’s proprietary DSOX-15 and DSOX-20 Fuel Purification Systems are cost-effective technologies designed to remove sulfur from fuel to meet the imminent sulfur emissions regulations due to take effect in 2015. Triton anticipates that its solution will satisfy this 2015 requirement and the 2020 global requirement of .5 percent.

The Company was previously known as Poly Shield Technologies, Inc. It changed its corporate name to Triton Emission Solutions, Inc. last month. The Company’s shares trade on the OTC Markets’ OTCQB.

At present, the DSOX-15 and DSOX-20 Fuel Purification Systems are targeted at the maritime industry. This includes vessels for cruise-line, freight shipping and tanker companies. These technologies can be installed during normal vessel operation without the need to use expensive dry dock time. These technologies have global applications, which are not limited to the maritime industry.

Triton Emission Solutions has contracted with numerous shipping companies for installation of its DSOX-15 System, with options for a total of 62 installations. All of these will be upgraded to the new DSOX-20 System. The Company’s DSOX-20 fuel scrubber is a pre-combustion desulfurization system. It uses Triton’s proprietary and proven technology as its basis.

Through integrating this proven platform with additional new proprietary technologies that react and release the sulfur in the fuel, the Company’s DSOX-20 system can scrub and wash the sulfur from the fuel. As a by-product, the system additionally removes other harmful alkali metals including vanadium, sodium and calcium. 

This week, Triton Emission Solutions announced that the main components of its DSOX-20 Fuel Purification System for the project known as "Poseidon" have shipped to the customer. Triton expects completion of the installation in Q4 of this year.

Triton Emission Solutions, Inc. (DSOX), closed Friday's trading session at $0.43, up 0.47%, on 61,510 volume with 25 trades. The average volume for the last 60 days is 10,990 and the stock's 52-week low/high is $0.36/$1.22.

Reven Housing REIT, Inc. (RVEN)

Today we are reporting on Reven Housing REIT, Inc. (RVEN), here at the QualityStocks Daily Newsletter.

Reven Housing REIT, Inc. is an internally-managed real estate investment company listed on the OTC Bulletin Board. It focuses on the acquisition, leasing, and management of recently renovated and stabilized single-family properties in select markets in the U.S. The Company generates almost all of its revenue through leasing its portfolio of single-family properties. Reven Housing REIT has its corporate headquarters in La Jolla, California.

The Company’s business plan involves acquiring portfolios of rented houses from investors who have bought them low, fixed and rented them. Its business plan also involves generating current income from profits from rentals and appreciation of houses.

As at June 30, 2014, the Company owned 177 single-family properties. Of these, 168 are in the Houston, Texas metropolitan area and nine are in the Atlanta, Georgia metropolitan area. Reven is looking to acquire portfolios of tenant occupied single family houses, (SFR) throughout the United States in either all cash or “umbrella partnership REIT" (UPREIT) transactions to sellers. Reven Housing REIT launched its business plan to acquire portfolios of SFR's in 2012.

The Company’s intention is to expand throughout the U.S. Reven’s mission is to be a leading national single family housing REIT. Its intention is to take all required steps to qualify as a real estate investment trust (REIT) under the Internal Revenue Code, as amended. 

In July, Reven Housing REIT announced that it acquired a portfolio of 46 single-family homes in the Jacksonville, Florida, metropolitan area. The 46 acquired properties average 1,322 square feet. They are mostly three-bedroom, one and a half bath homes.  Of the acquired properties, 37 are currently subject to one-year leases. Nine properties are subject to month-to-month leases.

In addition, in July, the Company announced that it acquired two portfolios totaling 61 single-family homes in Memphis, Tennessee, with one home just across the border in Mississippi. The acquired properties average 1,784 square feet and are mostly three-bedroom, two bath homes.  Of these properties, 43 are currently subject to one-year leases and four are subject to multi-year leases. The remaining 14 properties are subject to month-to-month leases.

Reven Housing REIT, Inc. (RVEN), closed Friday's trading session at $0.74, down 1.33%, on 1,630 volume with 3 trades. The average volume for the last 60 days is 7,974 and the stock's 52-week low/high is $0.38/$0.79.

New Energy Technologies, Inc. (NENE)

Penny Stock Rumble, TopStockAnalysts, and Top Gun reported previously on New Energy Technologies, Inc. (NENE), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

Listed on the OTCQB, New Energy Technologies, Inc. is the developer of SolarWindow™, the world’s first-of-its-kind see-through technology capable of generating electricity on glass and flexible plastics. The Company, together with its wholly-owned subsidiaries, is a developer of next generation alternative and renewable energy technologies. Furthermore, it is developing its MotionPower™ roadway systems. New Energy Technologies has its headquarters in Columbia, Maryland.

Its SolarWindow™ technologies enable see-through windows to generate electricity by ‘spraying’ its’ glass surfaces with the Company’s electricity-generating coatings. These solar coatings are less than 1/10th the thickness of thin films and use the world’s smallest functional solar cells, shown to successfully produce electricity, in a published peer-reviewed study in the Journal of Renewable and Sustainable Energy of the American Institute of Physics.

Additionally, New Energy Technologies’ MotionPower™ roadway systems are for generating electricity through capturing the kinetic energy produced by moving vehicles. This is a patent-pending technology, the subject of 59 U.S. and International patent applications. SolarWindow™ itself is now the subject of 42 U.S. and International patent filings. The Company’s technologies and products have been invented, designed, engineered, and prototyped in preparation for advanced field testing, product development, and commercial deployment.

With different active layer electricity-generating coatings, SolarWindow™ products may be manufactured with a variety of colors, levels of VLT, wavelength response, and power production, adapting to different building characteristics including color, power production, and energy offsetting requirements. The compatibility of SolarWindow™ with an assortment of active layer materials provides New Energy Technologies a way for future development of additional products and discoveries.

Last week, New Energy Technologies announced that it is successfully advancing continuing development of its SolarWindow™ devices and modules. Recently, its SolarWindow™ set a new record for generating electricity while remaining see-through. The Company’s engineers calculate that SolarWindow™ modules modeled for installation on a 50-story building could conservatively produce a minimum of ten times the electrical energy of conventional rooftop photovoltaic (PV) systems and, in some cases, exceed power performance by as much as 50-fold.

New Energy Technologies, Inc. (NENE), closed Friday's trading session at $1.40, up 2.19%, on 29,324 volume with 46 trades. The average volume for the last 60 days is 48,120 and the stock's 52-week low/high is $1.10/$3.61.


The QualityStocks
Company Corner


VistaGen Therapeutics, Inc. (VSTA)

The QualityStocks Daily Newsletter would like to spotlight VistaGen Therapeutics, Inc. (VSTA). Today, VistaGen Therapeutics, Inc. closed trading at $11.75, up 30.56%, on 100 volume with 1 trade. The stock’s average daily volume over the past 60 days is 5, and its 52-week low/high is $5.00/$17.80.

VistaGen Therapeutics, Inc. (VSTA) is a biotechnology company applying stem cell technology for drug rescue and cell therapy. Drug rescue combines human stem cell technology with modern medicinal chemistry to generate new chemical variants ("drug rescue variants") of once-promising drug candidates that have been discontinued during late-stage preclinical development due to heart or liver safety concerns. VistaGen also focuses on cell therapy, or regenerative medicine, which includes repairing, replacing or restoring damaged tissues or organs

VistaGen's versatile stem cell technology platform, Human Clinical Trials in a Test Tube™, has been developed to provide clinically relevant predictions of potential heart and liver toxicity of promising new drug candidates long before they are ever tested on humans.

By more closely approximating human biology than conventional animal studies and other nonclinical techniques and technologies currently used in drug development, VistaGen's human stem cell-based bioassay systems can improve the predictability of the drug development cycle and lower the cost of new drug research and development by identifying product failures earlier in the cost curve. According to the Food and Drug Administration even only a ten percent improvement in predicting failure before clinical trials could save $100 million in development costs, which savings ultimately could be passed on to patients.

Using mature human heart cells produced from stem cells, VistaGen has developed and internally validated CardioSafe 3D™, a novel three-dimensional (3D) bioassay system for predicting the in vivo cardiac effects of new drug candidates before they are tested in humans. VistaGen is now focused on using CardioSafe 3D™ to generate up to two new, safer small molecule drug rescue variants every twelve to eighteen months. VistaGen anticipates that these drug rescue variants will be modified versions of once-promising new drug candidates that have been discontinued by pharmaceutical companies and academic research institutions because of heart toxicity concerns, despite substantial prior investment and positive efficacy data demonstrating their potential therapeutic and commercial benefits. In most cases, VistaGen plans to license or sell its new, safer drug rescue variants in strategic partnering arrangements with global pharmaceutical companies, arrangements providing VistaGen with both near term and downstream milestone payments and economic participation rights but without future development cost obligations.

AV-101, VistaGen's lead small molecule prodrug candidate, has successfully completed Phase I clinical development in the U.S. for treatment of neuropathic pain, a serious and chronic condition affecting millions of people worldwide, depression, and other neurological diseases and conditions. To date, the U.S. National Institutes of Health (NIH) has awarded VistaGen over $8.75 million for development of AV-101. Management anticipates strategically out-licensing AV-101 to a development and marketing partner in 2013.

VistaGen is also developing LiverSafe 3D™, a novel predictive liver toxicity and drug metabolism bioassay system for drug rescue applications. In parallel with drug rescue activities, the Company is funding early-stage nonclinical studies focused on potential cell therapy applications of its Human Clinical Trials in a Test Tube™ platform. Disclaimer

VistaGen Therapeutics, Inc. Company Blog

VistaGen Therapeutics, Inc. News:

UPDATE: VistaGen Receives Notice of Allowance for Canadian Patent Further Expanding Stem Cell Technology Platform

VistaGen Announces Reverse Stock Split

VistaGen Receives Notice of Allowance for Canadian Patent Expanding Stem Cell Technology Platform

NutraNomics, Inc. (NNRX)

The QualityStocks Daily Newsletter would like to spotlight NutraNomics, Inc. (NNRX). Today, NutraNomics, Inc. closed trading at $0.048, up 17.07%, on 113,358 volume with 15 trades. The stock’s average daily volume over the past 60 days is 59,335, and its 52-week low/high is $0.04/$1.48.

NutraNomics, Inc. (NNRX) is focused on the research and development of nutritional dietary supplements, skin and body care products and transdermal patches. In addition to creating formulas for hundreds of companies, the company has produced and branded its own product lines which are sold through retail and wholesale channels. Additionally the company private labels and does custom manufacturing for several supplement companies in national and international markets.

Nearly all vitamins currently on the market are isolated and/or synthetic. The human body doesn’t recognize these types of vitamins and as a result cannot absorb them because they are either missing critical nutritional components or are not food based. NutraNomics has rapidly grown its business over the past 18 years by offering superior food and plant-based products blended from the highest quality sources available for maximum bioavailability.

Today NutraNomics has sales teams in seven different countries promoting its diversified line of wholefood-based supplements, specialty formulas, and remedies. All facilities used to produce the gluten-free, non-GMO nutritional products are cGMP Compliant and FDA approved. To ensure the highest purity potency and quality, the company takes it another step forward by performing additional content testing on all raw materials used to manufacture its products.

NutraNomics is more than just a health supplement provider. As a company dedicated to supporting the worldwide community of people who want to live healthy, NutraNomics is making an impact on those who are suffering from various types of diseases that need specialized diet to enhance their lifestyle. To fulfill this mission NutraNomics has invested in clinical studies for controlling diabetes, heart disease and cancer with dietary supplements. Strong growth is anticipated to continue as the company continues to introduce cutting-edge products and taps into new markets. Disclaimer

NutraNomics, Inc. Company Blog

NutraNomics, Inc. News:

NutraNomics Receives Initial Purchase Order for New Weight Loss Line of Products

Nutranomics Whole Food Based Vitamins and Supplements Reports Increase in Wholesale & Retail Sales

Nutranomics Whole Food Based Vitamins and Supplements Available on Amazon.com

Intelligent Highway Solutions, Inc. (IHSI)

The QualityStocks Daily Newsletter would like to spotlight Intelligent Highway Solutions, Inc. (IHSI). Today, Intelligent Highway Solutions, Inc. closed trading at $0.0799, up 14.14%, on 21,600 volume with 2 trades. The stock’s average daily volume over the past 60 days is 79,853, and its 52-week low/high is $0.07/$0.899.

Intelligent Highway Solutions, Inc. (IHSI) is a diversified technology-based electrical contracting company focused on the development and implementation of high and low voltage solutions across multiple platforms. Aside from years of business management and financing experience, IHSI’s executive team has more than 80 years of combined electrical background, creating the perfect backdrop and catalyst for the company’s recent entrance into the overlooked yet critical lighting segment of the billowing medical marijuana industry.

Through the development of proprietary wireless vehicle detection systems designed to make the nation's roadways more efficient, IHSI developed deep relationships with the transportation markets of local and state governments. These business relationships played a significant role in IHSI securing exclusive distribution rights to lighting systems developed by SCS Lighting Solutions, an engineering and electronics company specializing in solid state diode (SSD) lighting solutions.

The initial focus of the business relationship was for IHSI to offer SCS’s highly efficient, long-lasting lighting solutions to municipalities as a means to drastically reduce energy and maintenance costs. As a result, when the new business opportunity arrived to provide a low cost, energy efficient lighting technology for accelerating the growth of cannabis plants, IHSI already had the expertise and infrastructure needed to create a superior light for this specific purpose.

Currently estimated to generate annual sales of $1.5 billion in the U.S. alone, the medical marijuana industry is one of the world’s fastest growing markets. Leveraging a C-level team of electrical contractors backed by years of business management expertise, IHSI is positioned to cultivate sustainable growth in a key segment of the medical marijuana industry through its exclusive distribution rights to proprietary lighting systems designed to help legal cannabis growers reduce costs and improve yields. Disclaimer

Intelligent Highway Solutions, Inc. Company Blog

Intelligent Highway Solutions, Inc. News:

Intelligent Highway Solutions Announces Successful Test of Cannabis Lights and Additional Testing to Produce Greater Yields With New Prototype of Grow Light

Intelligent Highway Solutions Announces Shipment of Medical Marijuana Lights to Its First International Company Based in Canada

Intelligent Highway Solutions Finds Itself in the Right Place at the Right Time

Armco Metals Holdings, Inc. (AMCO)

The QualityStocks Daily Newsletter would like to spotlight Armco Metals Holdings, Inc. (AMCO). Today, Armco Metals Holdings, Inc. closed trading at $0.17, up 4.10%, on 34,170 volume with 19 trades. The stock’s average daily volume over the past 60 days is 249,569, and its 52-week low/high is $0.159/$0.58.

Armco Metals Holdings, Inc. (AMCO), since its founding 10 years ago, has tirelessly worked to create low-cost, high-quality solutions to meet steel industry demands and achieve its goal to become the largest scrap steel recycler in China. The company operates through five subsidiaries located in key regions throughout the country to source, import, process, and distribute quality, environmentally friendly recycled scrap steel, as well as metal and non-ferrous metal ore.

Subsidiaries Armco Metals International, Ltd., Armco (Lianyungang) Renewable Metals, Inc., Armet (Lianyungang) Holdings, Inc., Henan Armco & Metawise Trading Co., Ltd., Armco Metals (Shanghai) Holding, Ltd. support Armco Metal’s overarching corporate mission and operate to provide the country’s steel production industry with sustainable, responsible solutions to its material needs. Aligned with China’s green initiatives, Armco Metals and its subsidiaries are helping the government reach its scrap metal consumption goal of 20% by 2015.

Leveraging long-standing relationships with more than 10 international metal suppliers, more than 100 small- and medium-sized Chinese steel production companies, and some of the country’s large state-run foundries, Armco Metals benefits from a steady and dependable supply of demand for the company’s high-quality product known for excellent market values.

Armco Metals’ management team has established a unique approach to business and environment by providing responsible solutions based on environmentally friendly practices; reliable, cost-effective sourcing; and quality metal products. Backed by more than 10 years of industry experience, company executives have successfully positioned the company as credible, dependable partner for customers, suppliers, and investors within the steel production market. Disclaimer

Armco Metals Holdings, Inc. Company Blog

Armco Metals Holdings, Inc. News:

China's Ministry of Industry and Information Technology Approves Subsidiary

Armco Metals Holdings, Inc. Receives Government Approval to Import 20,000 Metric Tons of Restricted Materials Annually

Armco Metals Holdings, Inc. Receives $15 Million Credit Approval From a Chinese Commercial Bank

Pan Global Corp. (PGLO)

The QualityStocks Daily Newsletter would like to spotlight Pan Global Corp. (PGLO). Today, Pan Global Corp. closed trading at $0.0188, up 3.87%, on 114,654 volume with 10 trades. The stock’s average daily volume over the past 60 days is 877,890, and its 52-week low/high is $0.009/$0.96.

Pan Global Corp. (PGLO) is focused on building the world’s green economy by developing, building, owning, and operating the necessary infrastructure. Current opportunities are currently concentrated on developing projects in India, specifically in the areas of hydro-power generation, solar PV, geo-thermal, sustainable agriculture, and green construction.

The India growth story is frequently compared to China, which has sustained above-average annual growth for three decades, whereas India’s take-off growth began at a later stage. During the last decade, India’s growth has averaged approximately 8% per year. India is poised for high GDP growth that will be sustained for decades to come.

Within the Indian market there are available various government-backed incentives programs, including those which provide direct tariff subsidies as well as market-based tariff support through renewable energy credits. Assessing project viability on a case by case basis, Pan Global seeks to invest in projects both as owner-developers and/or as partners with other developers.

Pan Global’s business strategy is an extension of the company’s commitment to improve human well-being and social equity, while significantly reducing environmental risks and ecological scarcities. By developing a series of highly environmentally sustainable and high ROI projects, Pan Global aims to accelerate business growth. Disclaimer

Pan Global Corp. Company Blog

Pan Global Corp. News:

Pan Global, Corp. Comments on Industry Report That the India Renewable Energy Market Opportunity Is Worth USD $10.5 Billion by 2017

Pan Global, Corp. Shareholder Update: Small-Hydro Plant Connected to Power Grid in Northern India

Pan Global, Corp. Increases Equity Stake in 5.7 MW Small-Hydro Plant in Northern India


Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters





Information Solutions Group



By The Numbers Charts

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors


The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.


About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251